[Improvement in swallowing difficulties treated by subcutaneous apomorphine infusion after deep brain stimulation in Parkinson's disease]

M Bailbé; B Bataille; J Paquereau; S Lavazais; P Vandermarcq; R Gil

doi:10.1016/s0035-3787(04)70913-3

[Improvement in swallowing difficulties treated by subcutaneous apomorphine infusion after deep brain stimulation in Parkinson's disease]

Rev Neurol (Paris). 2004 Mar;160(3):352-3. doi: 10.1016/s0035-3787(04)70913-3.

[Article in French]

Authors

M Bailbé¹, B Bataille, J Paquereau, S Lavazais, P Vandermarcq, R Gil

Affiliation

¹ Cabinet Médical: Neurologie, Perpignan.

PMID: 15037851
DOI: 10.1016/s0035-3787(04)70913-3

Abstract

In Parkinson's patients, swallowing difficulties may result in inhalation pneumonia, with a potentially serious prognosis. They may be revealed by withdrawal of L-dopa, especially after deep brain stimulation surgery. The following two cases illustrate the usefulness of apomorphine.

Publication types

Case Reports
English Abstract

MeSH terms

Antiparkinson Agents / administration & dosage
Antiparkinson Agents / therapeutic use*
Apomorphine / administration & dosage
Apomorphine / therapeutic use*
Brain
Deglutition* / drug effects
Electric Stimulation Therapy / methods
Humans
Infusions, Parenteral
Male
Middle Aged
Parkinson Disease / complications*
Parkinson Disease / therapy

Substances

Antiparkinson Agents
Apomorphine